Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02098538
Title Regorafenib in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Memorial Sloan-Kettering Cancer Center
Indications

adenoid cystic carcinoma

Therapies

Regorafenib

Age Groups: adult
Covered Countries USA


No variant requirements are available.